Health Times of Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times of Africa.

Press releases published on May 22, 2026

34 minutes ago

Slim Tide Under Investigation: Critical Research Details Ingredients' Effectiveness for Metabolic & Digestive Support

Indeterminate GlobeNewswire

an hour ago

Calidi Biotherapeutics Provides Required NYSE American Disclosure

Indeterminate GlobeNewswire

an hour ago

GlycoPulse Claims Evaluated: Most Advanced Blood Sugar Support Ingredients for Healthy Glucose Management by Glyco Pulse

Indeterminate GlobeNewswire

2 hours ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

2 hours ago

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Indeterminate GlobeNewswire

3 hours ago

SCYNEXIS Announces One-for-Eight Reverse Stock Split

Indeterminate GlobeNewswire

3 hours ago

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

Indeterminate GlobeNewswire

3 hours ago

NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars

Indeterminate GlobeNewswire

3 hours ago

XTL Announces Receipt of Staff Delist Determination from Nasdaq

Indeterminate GlobeNewswire

3 hours ago

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Indeterminate GlobeNewswire

3 hours ago

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH

Indeterminate GlobeNewswire

3 hours ago

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026

Indeterminate GlobeNewswire

3 hours ago

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union

Indeterminate GlobeNewswire

5 hours ago

Vaya Health and Partners Health Management Announce Merger

Indeterminate GlobeNewswire

6 hours ago

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Indeterminate GlobeNewswire

6 hours ago

AI Saved Me Launches to Document How People Are Using AI in Everyday Life

Indeterminate GlobeNewswire

6 hours ago

TPA, NCPA Applaud Tennessee Law Banning PBMs from Owning Pharmacies

Indeterminate GlobeNewswire